Evaluating the contraceptive potential of active immunization against gonadotropin-releasing hormone
Reproduction · 2026
DOI: 10.1093/reprod/xaaf024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, 2026. Verfasst von Henryk F Urbanski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR, United States. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Vaccines, Contraceptive. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Humans and rhesus macaques are known to express two molecular forms of gonadotropin-releasing hormone (GnRH-I and GnRH-II), which appear to differentially contribute to the regulation of the menstrual cycle. Specifically, there is evidence to suggest that GnRH-I is the primary mediator of negative estrogen feedback to the hypothalamus and pituitary gland, while GnRH-II is the primary mediator of the positive feedback that stimulates the preovulatory surge of luteinizing hormone. Therefore, it is plausible that selective silencing of GnRH-II would block ovulation and lay the platform for development of a novel contraceptive. To test this possibility female rhesus macaques were actively immunized against GnRH-II (and/or GnRH-I), and serum estradiol and progesterone concentrations were monitored for an additional ∼2.5 years. Despite multiple booster immunizations every ∼6 weeks, and elevated GnRH antibody titers, none of the animals ceased ovulating (i.e., revealed by monthly peaks of serum progesterone concentrations followed by menstruation). Taken together, these findings question the efficacy of GnRH vaccines as a stratagem for selectively blocking ovulation in humans. However, they do not negate the potential value of pharmacological interventions aimed at selectively silencing GnRH-II function and its involvement in stimulating the preovulatory luteinizing hormone surge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR, United States.
- Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR, United States.
- Endocrine Technologies Core, Oregon National Primate Research Center, Beaverton, OR, United States.
- Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada.
ORCID-Profile: Henryk F Urbanski, Alejandro Lomniczi
Förderung
- NIH HHS
- NIA NIH HHS
- NICHD NIH HHS
- National Institutes of Health
Zitieren
APA
Urbanski, H. F., Slifka, M. K., Appleman, M. L., Thomas, A., Kohama, S. G., Erikson, D. W., & Lomniczi, A. (2026). Evaluating the contraceptive potential of active immunization against gonadotropin-releasing hormone. Reproduction. https://doi.org/10.1093/reprod/xaaf024
Vancouver
Urbanski HF, Slifka MK, Appleman ML, Thomas A, Kohama SG, Erikson DW, et al. Evaluating the contraceptive potential of active immunization against gonadotropin-releasing hormone. Reproduction. 2026. doi:10.1093/reprod/xaaf024
BibTeX
@article{Urbanski2026,
author = {Urbanski, Henryk F and Slifka, Mark K and Appleman, Maria Luisa and Thomas, Archana and Kohama, Steven G and Erikson, David W and Lomniczi, Alejandro},
title = {Evaluating the contraceptive potential of active immunization against gonadotropin-releasing hormone},
journal = {Reproduction},
year = {2026},
doi = {10.1093/reprod/xaaf024}
}
EUVIMED